SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The total revenue for the quarter ended June 2023 remained nearly unchanged at Rs. 7380.20 millions.Profit saw a slight increase of 12.93%to Rs. 1305.80  millions from Rs. 1156.30 millions.OP of the company witnessed a marginal growth to 1780.50 millions from 1757.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 7380.20 7294.60 1.17 7380.20 7294.60 1.17 32163.40 32175.10 -0.04
Other Income 368.00 277.90 32.42 368.00 277.90 32.42 1015.20 762.20 33.19
PBIDT 1780.50 1757.20 1.33 1780.50 1757.20 1.33 9009.30 8320.50 8.28
Interest 2.80 6.80 -58.82 2.80 6.80 -58.82 18.10 19.90 -9.05
PBDT 1950.70 1750.40 11.44 1950.70 1750.40 11.44 8981.50 8416.40 6.71
Depreciation 163.60 158.20 3.41 163.60 158.20 3.41 657.70 681.90 -3.55
PBT 1787.10 1592.20 12.24 1787.10 1592.20 12.24 8323.80 7734.50 7.62
TAX 481.30 435.90 10.42 481.30 435.90 10.42 2276.80 3968.70 -42.63
Deferred Tax -45.00 -34.70 29.68 -45.00 -34.70 29.68 -183.70 -105.00 74.95
PAT 1305.80 1156.30 12.93 1305.80 1156.30 12.93 6047.00 3765.80 60.58
Equity 1694.10 1694.10 0.00 1694.10 1694.10 0.00 1694.10 1694.10 0.00
PBIDTM(%) 24.13 24.09 0.15 24.13 24.09 0.15 28.01 25.86 8.32

Glaxosmithkline Phar Share Price

2451.80 32.70 (1.35%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×